Mammography Market Size to Worth US$ 4.8 Billion by 2030 – Exclusive Report by Precedence Research

According to Precedence Research, during the forecast period of 2022 to 2030, the global mammography market is estimated to develop at a compound annual growth rate (CAGR) of 8.01%. The global mammography market was valued at USD 2.4 billion in 2021, and it is predicted to exceed USD 4.8 billion by 2030. The study investigates several elements and their consequences on the growth of the mammography market.

Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1854

This report focuses on mammography market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall mammography market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.

Report Scope of the Mammography Market

The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

In-Depth Analysis on Competitive Landscape

The report sheds light on leading manufacturers of mammography, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of mammography has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.

Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the mammography market.

Some of the prominent players in the mammography market include:

• Hologic
• Fujifilm
• Siemens Healthcare
• Phillips Healthcare
• Toshiba Medical Systems
• GE Healthcare
• Metaltronica
• I.M.S. Srl
• Koninklijke Philips NV
• Gamma Medica, Inc.
• Konica Minolta Business Solutions India Private Limited
• Carestream Health.
• BMI Biomedical International SRL
• Canon Inc
• MetaltronicaSpA, PLANNED OY
• GENERAL MEDICAL ITALIA
• Villa Systems Medical SpA

Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1854

Segments Covered in the Report

By Product

• Film Screen Systems
• Digital Systems
• Analog Systems
• Biopsy Systems
• 3D Systems
• Others

By Technology

• Breast Tomosynthesis Mammography
• CAD Mammography
• Digital Mammography

By Modality

• Portable
• Non-Portable

By End Use

• Hospitals
• Special Clinics
• Diagnosis Centers
• Ambulatory Surgical Centers
• Educational & Research Institutes

Regional Segmentation

• Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America [United States, Canada, Mexico]
• South America [Brazil, Argentina, Columbia, Chile, Peru]
• Middle East & Africa [GCC, North Africa, South Africa]

Some of the important ones are:

• What can be the best investment choices for venturing into new product and service lines?
• What value propositions should businesses aim at while making new research and development funding?
• Which regulations will be most helpful for stakeholders to boost their supply chain network?
• Which regions might see the demand maturing in certain segments in near future?
• What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
• Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
• Which government regulations might challenge the status of key regional markets?
• How will the emerging political and economic scenario affect opportunities in key growth areas?
• What are some of the value-grab opportunities in various segments?
• What will be the barrier to entry for new players in the market?

Table of Contents

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Mammography Market 

5.1. COVID-19 Landscape: Mammography Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Mammography Market, By Product

8.1. Mammography Market, by Product, 2022-2030

8.1.1. Film Screen Systems

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Digital Systems

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Analog Systems

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Biopsy Systems

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. 3D Systems

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Others

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Mammography Market, By Technology

9.1. Mammography Market, by Technology e, 2022-2030

9.1.1. Breast Tomosynthesis Mammography

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. CAD Mammography

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Digital Mammography

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Mammography Market, By Modality 

10.1. Mammography Market, by Modality, 2022-2030

10.1.1. Portable

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Non-Portable

10.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Mammography Market, By End Use 

11.1. Mammography Market, by End Use, 2022-2030

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Special Clinics

11.1.2.1. Market Revenue and Forecast (2017-2030)

11.1.3. Diagnosis Centers

11.1.3.1. Market Revenue and Forecast (2017-2030)

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Forecast (2017-2030)

11.1.5. Educational & Research Institutes

11.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Mammography Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.1.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.1.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.2.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.2.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.3.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.3.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.6.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.7.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.7.4. Market Revenue and Forecast, by End Use (2017-2030)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2017-2030)

12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)

12.4.8.3. Market Revenue and Forecast, by Modality (2017-2030)

12.4.8.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.5.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.5.4. Market Revenue and Forecast, by End Use (2017-2030)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2017-2030)

12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)

12.5.6.3. Market Revenue and Forecast, by Modality (2017-2030)

12.5.6.4. Market Revenue and Forecast, by End Use (2017-2030)

Chapter 13. Company Profiles

13.1. Hologic

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Fujifilm

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Siemens Healthcare

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Phillips Healthcare

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Toshiba Medical Systems

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GE Healthcare

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Metaltronica

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. I.M.S. Srl

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Koninklijke Philips NV

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Gamma Medica, Inc

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1854

About Us

Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.

From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.

Contact Us:                  

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com